Почетна › Akutna mijeloidna leukemija › Род Ајланд › Providence

Kliničke studije za Akutna mijeloidna leukemija u gradu Providence, RI

11 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Providence i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2

Rhode Island Hospital, Providence

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2

Rhode Island Hospital, Providence

Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2

Rhode Island Hospital, Providence

Узраст 60 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07437950

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Тражи се учесникФаза 2

Rhode Island Hospital, Providence

Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2

Rhode Island Hospital, Providence

Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2

Rhode Island Hospital, Providence

Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06672146

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

Тражи се учесникФаза 3

Clinical Trial Site, Providence

Узраст 12 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07211958

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Тражи се учесникФаза 3

Rhode Island Hospital, Providence

6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2

Rhode Island Hospital, Providence

До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Тражи се учесникФаза 2/3

University of Rhode Island, Providence

Узраст од 18 до 80 · Оба пола · Ажурирано 5. 8. 2026. · NCT06788756

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

Тражи се учесникФаза 2

Lifespan Health System Rhode Island Hospital, Providence

Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT05442216

Studije za Akutna mijeloidna leukemija u drugim gradovima

Ostale studije u gradu Providence

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.